keyword
https://read.qxmd.com/read/38765052/comparison-of-inflammatory-markers-coagulation-indicators-and-outcomes-between-influenza-and-covid-19-infection-amongst-children-a-systematic-review-and-meta-analysis
#21
JOURNAL ARTICLE
Yutang Yang, Qi Zheng, Linlin Yang, Lei Wu
BACKGROUND: Influenza and COVID-19 patients share similar features and outcomes amongst adults. However, the difference between these diseases is not explored in paediatric age group especially in terms of inflammatory markers, coagulation profile and outcomes. Hence, we did this review to compare the inflammatory, coagulation features and outcomes between influenza and COVID-19 infected children. METHODS: Literature search was done in PubMed Central, Scopus, EMBASE, CINAHL, Cochrane library, Google Scholar & ScienceDirect from November 2019 to May 2022...
May 30, 2024: Heliyon
https://read.qxmd.com/read/38765009/a-murine-model-of-post-acute-neurological-sequelae-following-sars-cov-2-variant-infection
#22
JOURNAL ARTICLE
Ankita Singh, Awadalkareem Adam, Aditi, Bi-Hung Peng, Xiaoying Yu, Jing Zou, Vikram V Kulkarni, Peter Kan, Wei Jiang, Pei-Yong Shi, Parimal Samir, Irma Cisneros, Tian Wang
Viral variant is one known risk factor associated with post-acute sequelae of COVID-19 (PASC), yet the pathogenesis is largely unknown. Here, we studied SARS-CoV-2 Delta variant-induced PASC in K18-hACE2 mice. The virus replicated productively, induced robust inflammatory responses in lung and brain tissues, and caused weight loss and mortality during the acute infection. Longitudinal behavior studies in surviving mice up to 4 months post-acute infection revealed persistent abnormalities in neuropsychiatric state and motor behaviors, while reflex and sensory functions recovered over time...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38764565/utility-of-the-xpert-xpress-cov-2-flu-rsv-plus-kit-a-glance-at-rsv-infection-in-adults-and-coinfection-rate
#23
JOURNAL ARTICLE
Khaled R Alkharsah
BACKGROUND: Viral infection is responsible for the majority of respiratory tract infections (RTI). This retrospective study evaluates the advantages of using the multiplex Xpert Xpress CoV-2/Flu/RSV plus kit in laboratory diagnosis of RTI caused by the most related viruses. MATERIALS AND METHODS: Data were obtained from medical records between November 2021 and May 2023 for any sample tested using either the Xpert Xpress Flu/RSV kit, Xpert Xpress Flu kit, Xpert Xpress SARS-CoV-2 kit, and Xpert Xpress CoV-2/Flu/RSV plus kit...
2024: Saudi Journal of Medicine & Medical Sciences
https://read.qxmd.com/read/38764553/air-change-rate-and-sars-cov-2-exposure-in-hospitals-and-residences-a-meta-analysis
#24
JOURNAL ARTICLE
Yuetong Zhang, Sripriya Nannu Shankar, William B Vass, John A Lednicky, Z Hugh Fan, Duzgun Agdas, Robert Makuch, Chang-Yu Wu
As SARS-CoV-2 swept across the globe, increased ventilation and implementation of air cleaning were emphasized by the US CDC and WHO as important strategies to reduce the risk of inhalation exposure to the virus. To assess whether higher ventilation and air cleaning rates lead to lower exposure risk to SARS-CoV-2, 1274 manuscripts published between April 2020 and September 2022 were screened using key words "airborne SARS-CoV-2 or "SARS-CoV-2 aerosol". Ninety-three studies involved air sampling at locations with known sources (hospitals and residences) were selected and associated data were compiled...
2024: Aerosol Science and Technology: the Journal of the American Association for Aerosol Research
https://read.qxmd.com/read/38763751/computational-estimation-of-residues-involving-resistance-to-the-sars-cov-2-main-protease-inhibitor-ensitrelvir-based-on-virtual-alanine-scan-of-the-active-site
#25
JOURNAL ARTICLE
Ayato Mizuno, Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda
Ensitrelvir is a noncovalent inhibitor of the main protease (Mpro) of severe acute respiratory syndrome coronavirus 2. Acquisition of drug resistance in virus-derived proteins is a serious therapeutic concern, and drug resistance occurs due to amino acid mutations. In this study, we computationally constructed 24 mutants, in which one residue around the active site was replaced with alanine and performed molecular dynamics simulations to the complex of Mpro and ensitrelvir to predict the residues involved in drug resistance...
2024: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/38763750/ciclesonide-inhibits-sars-cov-2-papain-like-protease-in-vitro
#26
JOURNAL ARTICLE
Yuka Kiba, Takashi Tanikawa, Masashi Kitamura
The emergence of coronavirus disease 2019 (COVID-19), a novel identified pneumonia resulting from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has significantly impacted and posed significant challenges to human society. The papain-like protease (PLpro) found in the nonstructural protein 3 of SARS-CoV-2 plays a vital role in viral replication. Moreover, PLpro disrupts the host immune response by cleaving ubiquitin and interferon-stimulated gene 15 from host proteins. Consequently, PLpro has emerged as a promising drug target against SARS-CoV-2 infection...
2024: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/38763300/associations-between-genetic-mutations-in-different-sars-cov-2-strains-and-negative-conversion-time-of-viral-rna-among-imported-cases-in-hangzhou-a-cross-sectional-study
#27
JOURNAL ARTICLE
Yi Wang, Hua Yu, Tao Zhang, Zhou Sun, Wenwu Yao, Wenhui Zhang, Qian Chen, Yao Zhong, Qian Huang, Meihua Wang, Haoqiu Wang, Beibei Wu
PURPOSE: Previous studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have focused on factors that influence the achievement of negative conversion of viral RNA. This study aimed to investigate the effects of the genetic mutations in different SARS-CoV-2 strains on the negative conversion time (NCT) among imported cases in Hangzhou, Zhejiang Province, China, in order to provide valuable insights for developing targeted epidemic prevention guidelines. METHODS: This retrospective study involved 146 imported SARS-CoV-2 cases in Hangzhou from 8 April 2021 to 11 June 2022...
May 17, 2024: Virus Research
https://read.qxmd.com/read/38763199/photoluminescence-based-biosensor-for-the-detection-of-antibodies-against-sars-cov-2-virus-proteins-by-zno-tetrapod-structure-integrated-within-microfluidic-system
#28
JOURNAL ARTICLE
Roman Viter, Iryna Tepliakova, Maryia Drobysh, Viktor Zbolotnii, Simas Rackauskas, Simonas Ramanavicius, Karlis Grundsteins, Viktorija Liustrovaite, Almira Ramanaviciene, Vilma Ratautaite, Ernestas Brazys, Chien-Fu Chen, Urte Prentice, Arunas Ramanavicius
This paper reports on development of an optical biosensor for the detection of antibodies against SARS-CoV-2 virus proteins in blood serum. ZnO nanotetrapods with high surface area and stable room temperature photoluminescence (PL) were selected as transducers. Structure and optical properties of the ZnO tetrapods have been studied by XRD, SEM and Raman spectroscopy. Crystallinity, dimensions and emission peaks of the ZnO tetrapods were determined. The ZnO tetrapods were fixed on glass chip. Silanization of ZnO tetrapods surface resulted in forming of functional surface groups suitable for the immobilization of bioselective layer...
May 17, 2024: Science of the Total Environment
https://read.qxmd.com/read/38763190/the-role-of-catchment-population-size-data-normalization-and-chronology-of-public-health-interventions-on-wastewater-based-covid-19-viral-trends
#29
JOURNAL ARTICLE
Golam Islam, Ashley Gedge, Reeta Ibrahim, Tomas de Melo, Linda Lara-Jacobo, Thomas Dlugosz, Andrea E Kirkwood, Denina Simmons, Jean-Paul Desaulniers
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic presented the most challenging global crisis in recent times. A pandemic caused by a novel pathogen such as SARS-CoV-2 necessitated the development of innovative techniques for the monitoring and surveillance of COVID-19 infections within communities. Wastewater surveillance (WWS) is recognized as a non-invasive, cost-effective, and valuable epidemiological tool to monitor the prevalence of COVID-19 infections in communities. Seven municipal wastewater sampling sites representing distinct sewershed communities were selected for the surveillance of the SARS-CoV-2 virus in Durham Region, Ontario, Canada over 8 months from March 2021 to October 2021...
May 17, 2024: Science of the Total Environment
https://read.qxmd.com/read/38762525/direct-comparison-of-sars-cov-2-variant-specific-neutralizing-antibodies-in-human-and-hamster-sera
#30
JOURNAL ARTICLE
Annika Rössler, Antonia Netzl, Ludwig Knabl, Samuel H Wilks, Barbara Mühlemann, Sina Türeli, Anna Mykytyn, Dorothee von Laer, Bart L Haagmans, Derek J Smith, Janine Kimpel
Antigenic characterization of newly emerging SARS-CoV-2 variants is important to assess their immune escape and judge the need for future vaccine updates. To bridge data obtained from animal sera with human sera, we analyzed neutralizing antibody titers in human and hamster single infection sera in a highly controlled setting using the same authentic virus neutralization assay performed in one laboratory. Using a Bayesian framework, we found that titer fold changes in hamster sera corresponded well to human sera and that hamster sera generally exhibited higher reactivity...
May 18, 2024: NPJ Vaccines
https://read.qxmd.com/read/38762404/serologic-evaluation-for-severe-acute-respiratory-syndrome-coronavirus-2-in-pediatric-heart-transplantation-recipients-and-patients-on-a-pediatric-heart-transplantation-waiting-list-in-a-quaternary-hospital
#31
JOURNAL ARTICLE
Clarice Arruda Villari, Adailson Siqueira, Celia Strunz, Christiane Moscan, Marcelo Jatene, Nana Miura, Estela Azeka
BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic has been a global reality for longer than 3 years. Serologic studies have great importance for understanding the virus's behavior in populations, as it can suggest the status of the epidemic in a community. This cross-sectional study aimed to analyze the serologic profile for COVID-19 in patients before and after pediatric heart transplantation. METHODS: Serology data on IgG and IgM antibodies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were collected in patients of the Pediatric Cardiology and Congenital Heart Diseases unit of a Brazilian hospital between January and August 2022...
May 17, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38762360/interchangeability-of-different-covid-19-vaccine-platforms-as-booster-doses-a-phase-3-study-mimicking-real-world-practice
#32
JOURNAL ARTICLE
Sue Ann Costa Clemens, Lily Weckx, Eveline P Milan, Igor Smolenov, Ralf Clemens
BACKGROUND: The COVID-19 pandemic is over but the highly immunized or naturally exposed global population still requires booster vaccinations against newly emerging SARS-CoV-2 variants. We assessed safety and immunogenicity of booster doses of COVID-19 vaccines based on three different platforms in a setting that mimics the current routine practice in Brazil. METHODS: In this phase 3 study from 14 February 2023 to 12 June 2023 we enrolled previously immunized adults to receive an additional booster dose of one of three vaccines...
May 17, 2024: Vaccine
https://read.qxmd.com/read/38762278/decoding-macrophage-immunometabolism-in-human-viral-infection
#33
REVIEW
Takhellambam Malemnganba, Aditi Rattan, Vijay Kumar Prajapati
Immune-metabolic interactions play a pivotal role in both host defense and susceptibility to various diseases. Immunometabolism, an interdisciplinary field, seeks to elucidate how metabolic processes impact the immune system. In the context of viral infections, macrophages are often exploited by viruses for their replication and propagation. These infections trigger significant metabolic reprogramming within macrophages and polarization of distinct M1 and M2 phenotypes. This metabolic reprogramming involves alterations in standard- pathways such as the Krebs cycle, glycolysis, lipid metabolism, the pentose phosphate pathway, and amino acid metabolism...
2024: Advances in Protein Chemistry and Structural Biology
https://read.qxmd.com/read/38762086/targeting-furin-a-cellular-proprotein-convertase-for-covid-19-prevention-and-therapeutics
#34
REVIEW
Xia Jiang, Dabing Li, Mazaher Maghsoudloo, Xinghai Zhang, Wenzhe Ma, Junjiang Fu
SARS-CoV-2 has triggered an international outbreak of the highly contagious acute respiratory disease known as COVID-19. Identifying key targets in the virus infection lifecycle is crucial for developing effective prevention and therapeutic strategies against it. Furin is a serine endoprotease that belongs to the family of proprotein convertases and plays a critical role in the entry of host cells by SARS-CoV-2. Furin can cleave a specific S1/S2 site, PRRAR, on the spike protein of SARS-CoV-2, which promotes viral transmission by facilitating membrane fusion...
May 16, 2024: Drug Discovery Today
https://read.qxmd.com/read/38761981/a-high-throughput-response-to-the-sars-cov-2-pandemic
#35
JOURNAL ARTICLE
Lynn Rasmussen, Shalisa Sanders, Melinda Sosa, Sara McKellip, N Miranda Nebane, Yohanka Martinez-Gzegozewska, Andrew Reece, Pedro Ruiz, Anna Manuvakhova, Ling Zhai, Brooke Warren, Aliyah Curry, Qinghua Zeng, J Robert Bostwick, Paige N Vinson
Four years after the beginning of the COVID-19 pandemic, it is important to reflect on the events that have occurred during that time and the knowledge that has been gained. The response to the pandemic was rapid and highly resourced; it was also built upon a foundation of decades of federally funded basic and applied research. Laboratories in government, pharmaceutical, academic, and non-profit institutions all played roles in advancing pre-2020 discoveries to produce clinical treatments. This perspective provides a summary of how the development of high-throughput screening methods in a biosafety level 3 (BSL-3) environment at Southern Research Institute (SR) contributed to pandemic response efforts...
May 16, 2024: SLAS Discovery
https://read.qxmd.com/read/38761799/structural-basis-of-broad-sars-cov-2-cross-neutralization-by-affinity-matured-public-antibodies
#36
JOURNAL ARTICLE
Daniel J Sheward, Pradeepa Pushparaj, Hrishikesh Das, Allison J Greaney, Changil Kim, Sungyong Kim, Leo Hanke, Erik Hyllner, Robert Dyrdak, Jimin Lee, Xaquin Castro Dopico, Pia Dosenovic, Thomas P Peacock, Gerald M McInerney, Jan Albert, Martin Corcoran, Jesse D Bloom, Ben Murrell, Gunilla B Karlsson Hedestam, B Martin Hällberg
Descendants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant now account for almost all SARS-CoV-2 infections. The Omicron variant and its sublineages have spike glycoproteins that are highly diverged from the pandemic founder and first-generation vaccine strain, resulting in significant evasion from monoclonal antibody therapeutics and vaccines. Understanding how commonly elicited antibodies can broaden to cross-neutralize escape variants is crucial. We isolate IGHV3-53, using "public" monoclonal antibodies (mAbs) from an individual 7 months post infection with the ancestral virus and identify antibodies that exhibit potent and broad cross-neutralization, extending to the BA...
May 15, 2024: Cell reports medicine
https://read.qxmd.com/read/38761778/safety-and-immunogenicity-of-corenapcin-a-sars-cov-2-mrna-vaccine-as-a-fourth-heterologous-booster-in-healthy-iranian-adults-a-double-blind-randomized-placebo-controlled-phase-1-clinical-trial-with-a-six-month-follow-up
#37
JOURNAL ARTICLE
Mohammadreza Salehi, Ilad Alavi Darazam, Alireza Nematollahi, Masoumeh Alimohammadi, Sedigheh Pouya, Reza Alimohammadi, Nasim Khajavirad, Meysam Porgoo, Mosslim Sedghi, Mohammad Mahdi Sepahi, Maryam Azimi, Hamed Hosseini, Seyed Mahmoud Hashemi, Somaye Dehghanizadeh, Vahid Khoddami
UNLABELLED: The recurrent COVID-19 infection, despite global vaccination, highlights the need for booster doses. A heterologous booster has been suggested to enhance immunity and protection against emerging variants of concern of the SARS-CoV-2 virus. In this report, we aimed to assess the safety, and immunogenicity of COReNAPCIN, as a fourth booster dose after three doses of inactivated vaccines. METHODS: The study was conducted as a double-blind, randomized, placebo-controlled phase 1 clinical trial of the mRNA-based vaccine candidate, COReNAPCIN...
May 17, 2024: International Immunopharmacology
https://read.qxmd.com/read/38761661/rapid-one-pot-isothermal-amplification-reassembled-of-fluorescent-rna-aptamer-for-sars-cov-2-detection
#38
JOURNAL ARTICLE
Jia-Min Peng, Hao Liu, Zhan-Ming Ying
The outbreak of SARS-CoV-2 poses a serious threat to human life and health. A rapid nucleic acid tests can effectively curb the spread of the disease. With the advantages of fluorescent RNA aptamers, low background and high sensitivity. A variety of fluorescent RNA aptamer sensors have been developed for the detection of nucleic acid. Here, we report a hypersensitive detection platform in which SARS-CoV-2 initiates RTF-EXPAR to amplify trigger fragments. This activation leads to the reassembled of the SRB2 fluorescent RNA aptamer, restoring its secondary structure for SR-DN binding and turn-on fluorescence...
May 17, 2024: Talanta
https://read.qxmd.com/read/38760804/scarlet-supplemental-citicoline-administration-to-reduce-lung-injury-efficacy-trial-study-protocol-for-a-single-site-double-blinded-placebo-controlled-and-randomized-phase-1-2-trial-of-i-v-citicoline-cdp-choline-in-hospitalized-sars-cov-2-infected-patients
#39
JOURNAL ARTICLE
Sonal Pannu, Matthew C Exline, Joseph S Bednash, Joshua A Englert, Philip Diaz, Amy Bartlett, Guy Brock, Qing Wu, Ian C Davis, Elliott D Crouser
BACKGROUND: The SARS CoV-2 pandemic has resulted in more than 1.1 million deaths in the USA alone. Therapeutic options for critically ill patients with COVID-19 are limited. Prior studies showed that post-infection treatment of influenza A virus-infected mice with the liponucleotide CDP-choline, which is an essential precursor for de novo phosphatidylcholine synthesis, improved gas exchange and reduced pulmonary inflammation without altering viral replication. In unpublished studies, we found that treatment of SARS CoV-2-infected K18-hACE2-transgenic mice with CDP-choline prevented development of hypoxemia...
May 18, 2024: Trials
https://read.qxmd.com/read/38759027/neonatal-covid-19-treatment-are-there-new-chances
#40
REVIEW
M S Elfarargy, T A Alruwaili, A R Ahmad, D H Elbadry
Coronavirus disease 2019 (COVID-19) is considered an infectious disease which is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neonatal COVID-19 had been occurred in many countries which would indicate the need of effective and safe treatment for these vulnerable group. In this study, we showed symptoms of corona virus in neonates, investigation of coronavirus in neonates and radiological features of neonatal COVID-19. In addition, we discussed management of neonates with COVI-19, antiviral treatment, monoclonal antibodies administration, immunomodulatory therapy, antibiotics, vitamins, and minerals in the treatment of neonatal COVID-19, and also telemedicine in neonatal COVID-19 and feeding the newborn of COVID-19 mother...
May 11, 2024: Journal of Neonatal-perinatal Medicine
keyword
keyword
22048
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.